BECTON, DICKINSON AND COMPANY Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
BECTON, DICKINSON AND COMPANY (BDX) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $362.88 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-11-21.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2012-11-21
- BECTON, DICKINSON AND COMPANY income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $362.88M, a 12.98% decline from fiscal 2011.
- BECTON, DICKINSON AND COMPANY income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $417.00M, a 7.72% decline from fiscal 2010.
- BECTON, DICKINSON AND COMPANY income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $451.90M.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-09-30 | $362.88M 10-K · filed 2012-11-21 |
| 2011-09-30 | $417.00M 10-K · filed 2012-11-21 |
| 2010-09-30 | $451.90M 10-K · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |